Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.58 |
| ▸ | CES1 | P23141 | 4/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.44 |
| ▸ | FEN1 | P39748 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | GSK3B | P49841 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | ALB | P02768 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30712874 | 1.00 | CES2 (0.58) | CES2CES1ALDH1A1ALOX15GAA | |
| SCHEMBL1743417 | 0.85 | CES2 (0.56) | CES2CES1ALDH1A1ALOX15GAA | |
| SCHEMBL28872295 | 0.83 | ALDH1A1 (0.55) | CES2CES1ALDH1A1ALOX15GAA | |
| SCHEMBL1155548 | 0.83 | CES2 (0.55) | CES2CES1ALDH1A1ALOX15GAA | |
| SCHEMBL27670818 | 0.80 | CES2 (0.51) | CES2CES1ALDH1A1ALOX15GAA | |
| SCHEMBL30081002 | 0.80 | CES2 (0.60) | CES2CES1ALDH1A1ALOX15GAA | |
| SCHEMBL9312422 | 0.80 | CES2 (0.60) | CES2CES1ALDH1A1ALOX15GAA | |
| SCHEMBL30682655 | 0.80 | CES2 (0.60) | CES2CES1ALDH1A1ALOX15GAA | |
| SCHEMBL888679 | 0.78 | CES2 (0.58) | CES2CES1ALDH1A1ALOX15GAA | |
| SCHEMBL9861760 | 0.78 | ALDH1A1 (0.59) | CES2CES1ALDH1A1ALOX15GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260070892-A1 | FUNCTIONALIZED AMINOTRIAZINES | LEADXPRO AG (CH) | 2026-03-12 | — | — | US | disclosed |
| US-12391670-B2 | Functionalized aminotriazines | LEADXPRO AG (CH) | 2025-08-19 | — | — | US | disclosed |
| CN-112955441-B | Functionalized aminotriazines | 里德埃克斯普洛股份公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-117285411-A | Preparation method of 2' -bromo-o-fluoro acetophenone | 扬州市普林斯医药科技有限公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-117285411-A | Preparation method of 2' -bromo-o-fluoro acetophenone | 扬州市普林斯医药科技有限公司 | 2023-12-26 | — | — | CN | disclosed |
| EP-3870573-B1 | FUNCTIONALIZED AMINOTRIAZINES | LEADXPRO AG (CH) | 2023-08-02 | — | — | EP | disclosed |
| EP-3870573-B1 | FUNCTIONALIZED AMINOTRIAZINES | LEADXPRO AG (CH) | 2023-08-02 | — | — | EP | disclosed |
| US-20210395225-A1 | FUNCTIONALIZED AMINOTRIAZINES | LEADXPRO AG (CH) | 2021-12-23 | — | — | US | disclosed |
| US-20210395225-A1 | FUNCTIONALIZED AMINOTRIAZINES | LEADXPRO AG (CH) | 2021-12-23 | — | — | US | disclosed |
| CN-112955441-A | Functionalized aminotriazines | 里德埃克斯普洛股份公司 | 2021-06-11 | — | — | CN | disclosed |
| WO-2020083957-A1 | FUNCTIONALIZED AMINOTRIAZINES | LEADXPRO AG (CH) | 2020-04-30 | — | — | WO | disclosed |
| WO-2010046780-A2 | ANTI VIRAL COMPOUNDS | INSTITUT PASTEUR KOREA (KR) | 2010-04-29 | — | — | WO | disclosed |
| WO-2010046780-A2 | ANTI VIRAL COMPOUNDS | INSTITUT PASTEUR KOREA (KR) | 2010-04-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210395225-A1 | FUNCTIONALIZED AMINOTRIAZINES | TBXA2R, ADORA2B, ADORA2A | CES2 3637/4885CES1 1106/4885ALDH1A1 778/4885 |
| US-20260070892-A1 | FUNCTIONALIZED AMINOTRIAZINES | ADORA2B, TBXA2R, CNR1 | CES2 2901/4885CES1 764/4885ALDH1A1 448/4885 |
| US-12391670-B2 | Functionalized aminotriazines | TBXA2R, ADORA2B, ADORA2A | CES2 3619/4885CES1 1088/4885ALDH1A1 773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.